Camlin Fine Sciences Receives ₹5.47 Crore Income Tax Demand Notice for AY 2023-24

1 min read     Updated on 11 Apr 2026, 12:19 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Camlin Fine Sciences Limited has received an income tax demand notice of ₹5,46,98,560 for Assessment Year 2023-24 related to transfer pricing adjustments on transactions with Associated Enterprises. The company disclosed this to stock exchanges under SEBI regulations and stated it plans to file an appeal against the order. The company has clarified that there is no immediate impact on its financial or operational activities due to this development.

powered bylight_fuzz_icon
37392579

*this image is generated using AI for illustrative purposes only.

Camlin Fine Sciences Limited has received a significant income tax demand notice of ₹5,46,98,560 for Assessment Year 2023-24, the company disclosed to stock exchanges on April 10, 2026. The notice was issued under section 156 of the Income-Tax Act, 1961, following an Assessment Order from the Income Tax Department's Assessment Unit.

Details of the Tax Demand

The demand notice requires the company to deposit the specified amount within 30 days of service. The primary reason for this substantial demand relates to transfer pricing adjustments, specifically concerning Arm's Length Price adjustments for international and domestic transactions entered into by the company with its Associated Enterprises.

Parameter Details
Issuing Authority Assessment Unit, Income Tax Department
Demand Amount ₹5,46,98,560
Assessment Year 2023-24
Legal Provision Section 156 of Income-Tax Act, 1961
Payment Timeline 30 days from service date
Receipt Date April 10, 2026

Nature of Assessment

The Assessment Order was issued under section 143(3) of the Income-Tax Act, 1961. The demand primarily stems from adjustments made to the Arm's Length Price regarding the value of transactions between Camlin Fine Sciences and its Associated Enterprises. This indicates that the tax authorities have questioned the pricing of inter-company transactions and made upward adjustments, resulting in additional tax liability.

Company's Response and Impact

Camlin Fine Sciences has stated that there is no immediate impact on the company's financial, operational, or other activities due to this order. The company has examined the assessment order and is currently in the process of filing an appeal against it. This suggests that the company disagrees with the tax authorities' assessment and intends to challenge the demand through the appellate process.

Regulatory Compliance

The company has fulfilled its disclosure obligations under Regulation 30 read with sub-para 20 of Para A of Part A of Schedule III of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. The disclosure was made simultaneously to both BSE Limited and the National Stock Exchange of India Limited, ensuring transparency with all stakeholders regarding this material development.

The disclosure was signed by Rahul Sawale, Company Secretary and VP Legal, indicating the seriousness with which the company is treating this matter and its commitment to proper corporate governance practices.

Historical Stock Returns for Camlin Fine Sciences

1 Day5 Days1 Month6 Months1 Year5 Years
-0.13%+10.90%+32.72%-28.03%-9.74%-15.59%

How might this transfer pricing dispute affect Camlin Fine Sciences' future international expansion and subsidiary structuring strategies?

What potential impact could a prolonged appellate process have on the company's cash flow and working capital management?

Will this tax demand prompt increased regulatory scrutiny of transfer pricing practices across the broader chemical and fine sciences industry?

Camlin Fine Sciences Submits SEBI Compliance Certificate for Q4FY26

1 min read     Updated on 08 Apr 2026, 06:36 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Camlin Fine Sciences Limited submitted its compliance certificate under SEBI Depositories Regulations for Q4FY26 to BSE and NSE on April 8, 2026. The certificate, issued by registrar MUFG Intime India Private Limited, confirms proper dematerialisation processes and regulatory compliance for the quarter ended March 31, 2026.

powered bylight_fuzz_icon
37199172

*this image is generated using AI for illustrative purposes only.

Camlin Fine Sciences Limited has submitted its quarterly compliance certificate under SEBI (Depositories and Participants) Regulations, 2018 to stock exchanges. The certificate pertains to the quarter ended March 31, 2026, and was filed with both BSE Limited and National Stock Exchange of India Limited on April 8, 2026.

Regulatory Compliance Submission

The company submitted the confirmation certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. Company Secretary and VP Legal Rahul Sawale signed and submitted the compliance document to ensure adherence to regulatory requirements.

Parameter Details
Regulation SEBI (Depositories and Participants) Regulations, 2018 - Section 74(5)
Quarter Period March 31, 2026
Submission Date April 8, 2026
Submitted By Rahul Sawale, Company Secretary & VP Legal

Registrar Confirmation

MUFG Intime India Private Limited, formerly Link Intime India Private Limited, serves as the Registrar and Share Transfer Agent for Camlin Fine Sciences Limited. The registrar issued the confirmation certificate on April 3, 2026, which was subsequently forwarded to the stock exchanges.

Certificate Confirmations

The registrar confirmed several key compliance aspects for the quarter:

  • Securities received from depository participants for dematerialisation were properly confirmed to depositories
  • All securities comprised in certificates have been listed on stock exchanges where earlier issued securities are listed
  • Security certificates received for dematerialisation were confirmed or rejected within prescribed timelines
  • Security certificates were mutilated and cancelled after due verification by depository participants
  • Depository names were substituted in the register of members as registered owners

Company Information

Detail Information
Registered Office Floor 2 to 5, In G.S. Point, CST Road, Kalina, Santacruz (East), Mumbai 400098
CIN L74100MH1993PLC075361
BSE Scrip Code 532834
NSE Symbol CAMLINFINE

The submission ensures Camlin Fine Sciences Limited maintains compliance with SEBI depositories regulations, confirming proper handling of securities dematerialisation processes during the quarter ended March 31, 2026.

Historical Stock Returns for Camlin Fine Sciences

1 Day5 Days1 Month6 Months1 Year5 Years
-0.13%+10.90%+32.72%-28.03%-9.74%-15.59%

Will SEBI introduce any new compliance requirements for depositories and participants in the upcoming quarters of 2026?

How might the transition from Link Intime to MUFG Intime India impact Camlin Fine Sciences' future share transfer processes?

What operational challenges could Camlin Fine Sciences face if dematerialisation volumes increase significantly in Q1 FY2027?

More News on Camlin Fine Sciences

1 Year Returns:-9.74%